NCT05602974View on ClinicalTrials.gov

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

NANot yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2027

Conditions
Hepatocellular CarcinomaNarrow MarginAdjuvant Stereotactic Body RadiotherapyHepatectomy
Interventions
RADIATION

stereotactic body radiation therapy

adjuvant stereotactic body radiation therapy

OTHER

regular follow-up

regular follow-up

Trial Locations (1)

310009

the second affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT05602974 - Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study | Biotech Hunter | Biotech Hunter